Structural Basis for the Development of Avian Virus Capsids That Display Influenza Virus Proteins and Induce Protective Immunity
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural Basis for the Development of Avian Virus Capsids That Display Influenza Virus Proteins and Induce Protective Immunity
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 89, Issue 5, Pages 2563-2574
Publisher
American Society for Microbiology
Online
2014-12-18
DOI
10.1128/jvi.03025-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection
- (2014) V. V. A. Mallajosyula et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biomimetic Antigenic Nanoparticles Elicit Controlled Protective Immune Response to Influenza
- (2013) Dustin P. Patterson et al. ACS Nano
- Chimeric Virus-Like Particle Vaccines Displaying Conserved Enterovirus 71 Epitopes Elicit Protective Neutralizing Antibodies in Mice through Divergent Mechanisms
- (2013) X. Ye et al. JOURNAL OF VIROLOGY
- Recent Advances in Mucosal Immunization Using Virus-like Particles
- (2013) Gaëlle Vacher et al. MOLECULAR PHARMACEUTICS
- Chimeric Infectious Bursal Disease Virus-Like Particles as Potent Vaccines for Eradication of Established HPV-16 E7–Dependent Tumors
- (2013) Juan Martin Caballero et al. PLoS One
- Protective Oral Vaccination against Infectious bursal disease virus Using the Major Viral Antigenic Protein VP2 Produced in Pichia pastoris
- (2013) Omid Taghavian et al. PLoS One
- Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines
- (2013) Y. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants
- (2013) Masaaki Kawano et al. VIROLOGY
- Design of Escherichia coli-Expressed Stalk Domain Immunogens of H1N1 Hemagglutinin That Protect Mice from Lethal Challenge
- (2012) G. Bommakanti et al. JOURNAL OF VIROLOGY
- Immunization with M2e-Displaying T7 Bacteriophage Nanoparticles Protects against Influenza A Virus Challenge
- (2012) Hamidreza Hashemi et al. PLoS One
- Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
- (2012) Natasha Kushnir et al. VACCINE
- Chimeric calicivirus-like particles elicit specific immune responses in pigs
- (2012) E. Crisci et al. VACCINE
- Virus-like particles: The new frontier of vaccines for animal viral infections
- (2012) Elisa Crisci et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Applications of viral nanoparticles in medicine
- (2011) Ibrahim Yildiz et al. CURRENT OPINION IN BIOTECHNOLOGY
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
- (2011) D. C. Ekiert et al. SCIENCE
- Current strategies for subunit and genetic viral veterinary vaccine development
- (2011) Alejandro Brun et al. VIRUS RESEARCH
- Virus-like particles in vaccine development
- (2010) António Roldão et al. Expert Review of Vaccines
- Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection
- (2010) K. El Bakkouri et al. JOURNAL OF IMMUNOLOGY
- Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes
- (2010) T. T. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
- (2010) G. Bommakanti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development
- (2010) Zuzana Staneková et al. Virology Journal
- Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design
- (2010) Emily M. Plummer et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Influenza Virus Vaccine Based on the Conserved Hemagglutinin Stalk Domain
- (2010) J. Steel et al. mBio
- Broadly Protective Monoclonal Antibodies against H3 Influenza Viruses following Sequential Immunization with Different Hemagglutinins
- (2010) Taia T. Wang et al. PLoS Pathogens
- Electrostatic Interactions between Capsid and Scaffolding Proteins Mediate the Structural Polymorphism of a Double-stranded RNA Virus
- (2009) Irene Saugar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Infectious bursal disease virus is an icosahedral polyploid dsRNA virus
- (2009) D. Luque et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody Recognition of a Highly Conserved Influenza Virus Epitope
- (2009) D. C. Ekiert et al. SCIENCE
- Cross-Protective Potential of a Novel Monoclonal Antibody Directed against Antigenic Site B of the Hemagglutinin of Influenza A Viruses
- (2009) Reiko Yoshida et al. PLoS Pathogens
- The coming of age of virus-like particle vaccines
- (2008) Gary T. Jennings et al. BIOLOGICAL CHEMISTRY
- Exploiting viral properties for the rational design of modern vaccines
- (2008) Gunther Spohn et al. Expert Review of Vaccines
- Antigen delivery systems for veterinary vaccine development
- (2008) Alejandro Brun et al. VACCINE
- Vaccination and antigenic drift in influenza
- (2008) Maciej F. Boni VACCINE
- Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site
- (2008) Michelle Rémond et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More